Mylola 5gm Infusion

Introduction

Mylola is a prescription medication that contains the active ingredients L-Ornithine L-Aspartate. It is available in the form of an infusion and is commonly prescribed by healthcare professionals.

Uses

Mylola is primarily used to treat hepatic encephalopathy, a condition characterized by the buildup of toxins in the brain due to liver dysfunction. It helps to reduce the symptoms associated with hepatic encephalopathy and improve liver function.

Dosage and Administration

The dosage and administration of Mylola may vary depending on the individual patient’s condition and medical history. Follow the instructions provided by your healthcare professional. Typically, Mylola is administered intravenously under the supervision of a healthcare provider.

Mechanism of Action

Mylola contains L-Ornithine L-Aspartate, which works by promoting the detoxification of ammonia in the liver. It helps to improve the liver’s ability to metabolize ammonia, reducing its accumulation in the brain and improving cognitive function.

Side Effects

Common side effects may include nausea, vomiting, diarrhea, and abdominal pain. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, seek medical attention.

Drug Interactions

inform your healthcare professional about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. Mylola may interact with certain medications, such as diuretics or other medications that affect kidney function. Your healthcare professional will be able to determine if any potential drug interactions may exist.

Precautions

Before using Mylola, inform your healthcare professional about any known allergies or medical conditions you may have. Additionally, certain precautions should be taken. Mylola may not be suitable for individuals with severe liver disease or those who are pregnant or breastfeeding. Discuss the potential risks and benefits with your healthcare professional before starting this medication.

Storage

Mylola should be stored at room temperature, away from direct sunlight and moisture. It should be kept out of the reach of children and pets. Do not use the medication if the packaging is damaged or if the expiration date has passed.

Patient Tips

• Follow the dosage instructions provided by your healthcare professional.
• If you miss a dose, contact your healthcare professional for further guidance.
• If you experience any unusual or severe side effects, seek medical attention.
• Inform your healthcare professional about all medications you are currently taking.
• Store the medication as directed, away from heat and moisture.
• Keep all appointments with your healthcare professional for monitoring and follow-up.
• If you have any questions or concerns, do not hesitate to reach out to your healthcare professional for clarification.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Low blood sugar (hypoglycaemia) (NHS UK) [Accessed 3 Jun. 2024] (online) Available at:
• Numeta G13%E Preterm, emulsion for infusion (Health Professionals SmPC) Available at:
• Hepa-Merz (International database) (Drugs.com) [Accessed 21 Jun. 2024] (online) Available at:
• OTC gene (MedlinePlus) [Accessed 4 Jun. 2024] (online) Available at:
• Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, Sonika U, Dalal A. L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial. Hepatology. 2022 May;75(5):1194-1203. doi: 10.1002/hep.32255. Epub 2021 Dec 21. [Accessed 13 Jun. 2024] Available at: